With the rising trend of self‑administration for chronic diseases, the safety, portability, ease of operation and dosage accuracy of self‑administration devices have become key factors affecting long‑term medication for patients with chronic diseases. Featuring relatively simplified operation, intuitive dosage setting, convenient portability and low injection pain, pen‑injector systems have been widely applied in long‑term medication scenarios for chronic diseases such as diabetes and rheumatic immune disorders.
Traditional syringes suffer from multiple drawbacks in medication preparation, dosage adjustment and carrying: numerous operating steps and high exposure risks. During repeated aspiration, the risk of exposure and contamination of drug solution increases, and they are also inconvenient for elderly patients and people with weak hand strength. In view of this, Triumph Junheng has built a systematic solution covering performance verification and pharmaceutical packaging material compliance for pen‑injectors and supporting cartridge vials.
In terms of product design, the pen‑injectors of Triumph Junheng adopt an ergonomic pen‑shaped profile. The compact and lightweight body facilitates storage and carrying. Clear and intuitive graduations make it suitable for independent operation by elderly patients. When used together with cartridge vials, the product enables multi‑dose continuous administration, reduces exposure and contamination risks caused by repeated drug aspiration, and improves the safety and comfort of self‑injection. Meanwhile, the needle safety protection structure lowers the risk of accidental needlestick injuries, optimizes puncture feeling and alleviates patients’ fear of injection.
In respect of standards and compliance, the company’s pen‑injectors are strictly benchmarked against authoritative domestic and international industry standards. The design and production of the complete device comply with the international standard ISO11608‑1 for pen‑injector systems and the domestic medical device industry standard YY/T 1768.1‑2021. Key components of supporting cartridge vials including glass barrels, rubber pistons and sealing gaskets follow national pharmaceutical packaging material standards YBB00132004‑2015 and YBB00152004‑2015. They satisfy the relevant general requirements of the Chinese Pharmacopoeia and are compatible with USP and EP pharmacopoeia specifications to meet market‑access requirements both at home and abroad.
Regarding performance parameters, the single‑administration dosage error of the product is controlled within ≤±5%, with steady and even plunger propulsion. The maximum overall pushing force of the complete device is ≤15 N; the plunger moves smoothly without jamming, making it suitable for users with weak hand strength. The puncture depth is stably controlled within 4‑8 mm, balancing administration efficacy and low‑pain advantage. The standard configuration is adapted to mainstream 3 mL medium borosilicate cartridge vials. It is compatible with various preparations including insulin, peptides and immunological agents, fitting long‑term repeated self‑administration scenarios.
From the perspective of industry trends, as home‑based healthcare and self‑medication for chronic diseases keep advancing, safe, convenient and accurate drug‑delivery devices have become an important development direction. Going forward, Triumph Junheng will continuously optimize the performance of pen‑injectors and their supporting cartridge vials, strictly abide by quality standards for pharmaceutical packaging materials, and keep delivering stable, precise and safe drug‑delivery packaging solutions. The company will contribute to the high‑quality development of home‑based healthcare and safeguard patients’ medication safety.With the rising trend of self‑administration for chronic diseases, the safety, portability, ease of operation and dosage accuracy of self‑administration devices have become key factors affecting long‑term medication for patients with chronic diseases. Featuring relatively simplified operation, intuitive dosage setting, convenient portability and low injection pain, pen‑injector systems have been widely applied in long‑term medication scenarios for chronic diseases such as diabetes and rheumatic immune disorders. Traditional syringes suffer from multiple drawbacks in medication preparation, dosage adjustment and carrying: numerous operating steps and high exposure risks. During repeated aspiration, the risk of exposure and contamination of drug solution increases, and they are also inconvenient for elderly patients and people with weak hand strength. In view of this, **Triumph Junheng** has built a systematic solution covering performance verification and pharmaceutical packaging material compliance for pen‑injectors and supporting cartridge vials. In terms of product design, the pen‑injectors of **Triumph Junheng** adopt an ergonomic pen‑shaped profile. The compact and lightweight body facilitates storage and carrying. Clear and intuitive graduations make it suitable for independent operation by elderly patients. When used together with cartridge vials, the product enables multi‑dose continuous administration, reduces exposure and contamination risks caused by repeated drug aspiration, and improves the safety and comfort of self‑injection. Meanwhile, the needle safety protection structure lowers the risk of accidental needlestick injuries, optimizes puncture feeling and alleviates patients’ fear of injection. In respect of standards and compliance, the company’s pen‑injectors are strictly benchmarked against authoritative domestic and international industry standards. The design and production of the complete device comply with the international standard ISO11608‑1 for pen‑injector systems and the domestic medical device industry standard YY/T 1768.1‑2021. Key components of supporting cartridge vials including glass barrels, rubber pistons and sealing gaskets follow national pharmaceutical packaging material standards YBB00132004‑2015 and YBB00152004‑2015. They satisfy the relevant general requirements of the Chinese Pharmacopoeia and are compatible with USP and EP pharmacopoeia specifications to meet market‑access requirements both at home and abroad. Regarding performance parameters, the single‑administration dosage error of the product is controlled within ≤±5%, with steady and even plunger propulsion. The maximum overall pushing force of the complete device is ≤15 N; the plunger moves smoothly without jamming, making it suitable for users with weak hand strength. The puncture depth is stably controlled within 4‑8 mm, balancing administration efficacy and low‑pain advantage. The standard configuration is adapted to mainstream 3 mL medium borosilicate cartridge vials. It is compatible with various preparations including insulin, peptides and immunological agents, fitting long‑term repeated self‑administration scenarios. From the perspective of industry trends, as home‑based healthcare and self‑medication for chronic diseases keep advancing, safe, convenient and accurate drug‑delivery devices have become an important development direction. Going forward, **Triumph Junheng** will continuously optimize the performance of pen‑injectors and their supporting cartridge vials, strictly abide by quality standards for pharmaceutical packaging materials, and keep delivering stable, precise and safe drug‑delivery packaging solutions. The company will contribute to the high‑quality development of home‑based healthcare and safeguard patients’ medication safety.